Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 545 articles:
HTML format



Single Articles


    January 2020
  1. JAMSHIDII N, Chang J, Mock K, Nguyen B, et al
    Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0226634.
    PubMed     Abstract available


  2. PERRIER A, Boelle PY, Chretien Y, Gligorov J, et al
    An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    PLoS One. 2020;15:e0227356.
    PubMed     Abstract available


  3. WANG Q, Liu X, Ren S
    Tofu intake is inversely associated with risk of breast cancer: A meta-analysis of observational studies.
    PLoS One. 2020;15:e0226745.
    PubMed     Abstract available


  4. GRESNER P, Jablonska E, Gromadzinska J
    Rad51 paralogs and the risk of unselected breast cancer: A case-control study.
    PLoS One. 2020;15:e0226976.
    PubMed     Abstract available


  5. AL-WAJEEH AS, Salhimi SM, Al-Mansoub MA, Khalid IA, et al
    Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    PLoS One. 2020;15:e0227404.
    PubMed     Abstract available


  6. SHAMSI U, Khan S, Azam I, Habib Khan A, et al
    A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan.
    PLoS One. 2020;15:e0225402.
    PubMed     Abstract available


  7. ROJAS L, Muniz S, Medina L, Pena J, et al
    Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer.
    PLoS One. 2020;15:e0227961.
    PubMed     Abstract available


  8. FERREIRA LC, Orso F, Dettori D, Lacerda JZ, et al
    The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.
    PLoS One. 2020;15:e0228062.
    PubMed     Abstract available


  9. TFAILY MA, Nassar F, Sellam LS, Amir-Tidadini ZC, et al
    miRNA expression in advanced Algerian breast cancer tissues.
    PLoS One. 2020;15:e0227928.
    PubMed     Abstract available


  10. CHENG HG, Gonzalez-Reymundez A, Li I, Pathak A, et al
    Breast cancer survival and the expression of genes related to alcohol drinking.
    PLoS One. 2020;15:e0228957.
    PubMed     Abstract available


  11. JAMSHIDI N, Chang J, Mock K, Nguyen B, et al
    Correction: Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0229584.
    PubMed     Abstract available


  12. LEE S, Liang X, Woods M, Reiner AS, et al
    Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
    PLoS One. 2020;15:e0226157.
    PubMed     Abstract available


  13. MU Q, Yu J, Griffin JI, Wu Y, et al
    Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
    PLoS One. 2020;15:e0228557.
    PubMed     Abstract available


  14. LI M, Han M, Chen Z, Tang Y, et al
    Does marital status correlate with the female breast cancer risk? A systematic review and meta-analysis of observational studies.
    PLoS One. 2020;15:e0229899.
    PubMed     Abstract available


  15. RATH M, Li Q, Li H, Lindstrom S, et al
    Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
    PLoS One. 2020;15:e0230529.
    PubMed     Abstract available


  16. AN YY, Kim SH, Kang BJ, Suh YJ, et al
    Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
    PLoS One. 2020;15:e0230347.
    PubMed     Abstract available


  17. KUSI G, Boamah Mensah AB, Boamah Mensah K, Dzomeku VM, et al
    Caregiving motivations and experiences among family caregivers of patients living with advanced breast cancer in Ghana.
    PLoS One. 2020;15:e0229683.
    PubMed     Abstract available


  18. VILLARREAL-GARZA C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, et al
    Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients.
    PLoS One. 2020;15:e0228884.
    PubMed     Abstract available


  19. MIAO LF, Ye XH, He XF
    Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    PLoS One. 2020;15:e0216147.
    PubMed     Abstract available


  20. HE TF, Yost SE, Frankel PH, Dagis A, et al
    Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis.
    PLoS One. 2020;15:e0229955.
    PubMed     Abstract available


  21. KIM YS, Sun S, Yoon JS, Ko YH, et al
    Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    PLoS One. 2020;15:e0230261.
    PubMed     Abstract available


  22. KALLARACKAL J, Burger F, Bianco S, Romualdi A, et al
    A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0230313.
    PubMed     Abstract available



  23. Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pat
    PLoS One. 2020;15:e0231282.
    PubMed    


  24. MARTINO G, Catalano A, Agostino RM, Bellone F, et al
    Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
    PLoS One. 2020;15:e0230681.
    PubMed     Abstract available


  25. LE DU F, Fujii T, Kida K, Davis DW, et al
    EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(R) in patients with breast cancer treated with primary systemic therapy.
    PLoS One. 2020;15:e0229903.
    PubMed     Abstract available


  26. LEE SB, Bose S, Ahn SH, Son BH, et al
    Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    PLoS One. 2020;15:e0231004.
    PubMed     Abstract available


  27. SCHNEIDER PP, Pouwels XGLV, Passos VL, Ramaekers BLT, et al
    Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
    PLoS One. 2020;15:e0230909.
    PubMed     Abstract available


  28. SMEDA M, Kij A, Proniewski B, Matyjaszczyk-Gwarda K, et al
    Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer.
    PLoS One. 2020;15:e0230520.
    PubMed     Abstract available


  29. BEAUCHAMP A, Mohebbi M, Cooper A, Pridmore V, et al
    The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials.
    PLoS One. 2020;15:e0226610.
    PubMed     Abstract available


  30. TUTZAUER J, Sjostrom M, Bendahl PO, Ryden L, et al
    Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
    PLoS One. 2020;15:e0231786.
    PubMed     Abstract available


  31. PALMER ACS, Zortea M, Souza A, Santos V, et al
    Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.
    PLoS One. 2020;15:e0231379.
    PubMed     Abstract available


  32. ZHANG H, Luo M, Liang X, Wang D, et al
    Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
    PLoS One. 2020;15:e0232166.
    PubMed     Abstract available


  33. DING Y, Ding K, Qian H, Yu X, et al
    Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0231895.
    PubMed     Abstract available


  34. KOROLKOVA OY, Widatalla SE, Whalen DS, Nangami GN, et al
    Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
    PLoS One. 2020;15:e0231711.
    PubMed     Abstract available


  35. PURRINGTON KS, Knight J 3rd, Dyson G, Ali-Fehmi R, et al
    CLCA2 expression is associated with survival among African American women with triple negative breast cancer.
    PLoS One. 2020;15:e0231712.
    PubMed     Abstract available


  36. ADAM A, Koranteng F
    Availability, accessibility, and impact of social support on breast cancer treatment among breast cancer patients in Kumasi, Ghana: A qualitative study.
    PLoS One. 2020;15:e0231691.
    PubMed     Abstract available


  37. HSU PC, Kadlubar SA, Siegel ER, Rogers LJ, et al
    Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.
    PLoS One. 2020;15:e0230248.
    PubMed     Abstract available


  38. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2020;15:e0225357.
    PubMed     Abstract available


  39. DOBROSSY B, Girasek E, Susanszky A, Koncz Z, et al
    "Clicks, likes, shares and comments" a systematic review of breast cancer screening discourse in social media.
    PLoS One. 2020;15:e0231422.
    PubMed     Abstract available


  40. WETSTEIN SC, Onken AM, Luffman C, Baker GM, et al
    Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.
    PLoS One. 2020;15:e0231653.
    PubMed     Abstract available


  41. EIRIKSSON FF, Nohr MK, Costa M, Bodvarsdottir SK, et al
    Lipidomic study of cell lines reveals differences between breast cancer subtypes.
    PLoS One. 2020;15:e0231289.
    PubMed     Abstract available


  42. PAMPHLETT R, Satgunaseelan L, Kum Jew S, Doble PA, et al
    Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers.
    PLoS One. 2020;15:e0228226.
    PubMed     Abstract available


  43. HUANG BARTLETT C, Mardekian J, Cotter MJ, Huang X, et al
    Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.
    PLoS One. 2020;15:e0227256.
    PubMed     Abstract available


  44. BOZEK A, Jarzab J, Mielnik M, Bogacz A, et al
    Can atopy have a protective effect against cancer?
    PLoS One. 2020;15:e0226950.
    PubMed     Abstract available


  45. ELLMANN S, Wenkel E, Dietzel M, Bielowski C, et al
    Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses.
    PLoS One. 2020;15:e0228446.
    PubMed     Abstract available


  46. ESPINOSA FERNANDEZ JR, Eckhardt BL, Lee J, Lim B, et al
    Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
    PLoS One. 2020;15:e0231953.
    PubMed     Abstract available


  47. PAL CHOUDHURY P, Maas P, Wilcox A, Wheeler W, et al
    iCARE: An R package to build, validate and apply absolute risk models.
    PLoS One. 2020;15:e0228198.
    PubMed     Abstract available


  48. LI M, Yue C, Zuo X, Jin G, et al
    The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province.
    PLoS One. 2020;15:e0232174.
    PubMed     Abstract available


  49. HADGU E, Seifu D, Tigneh W, Bokretsion Y, et al
    Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0232519.
    PubMed     Abstract available


  50. RINALDI J, Sokol ES, Hartmaier RJ, Trabucco SE, et al
    The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
    PLoS One. 2020;15:e0231999.
    PubMed     Abstract available


  51. LEE KN, Torres MA, Troeschel AN, He J, et al
    Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    PLoS One. 2020;15:e0232581.
    PubMed     Abstract available


  52. LI X, Shen X, Zhou Y, Wang X, et al
    Classification of breast cancer histopathological images using interleaved DenseNet with SENet (IDSNet).
    PLoS One. 2020;15:e0232127.
    PubMed     Abstract available


  53. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    PubMed     Abstract available


  54. GARCIA-VAZQUEZ V, Calvo FA, Ledesma-Carbayo MJ, Sole CV, et al
    Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations.
    PLoS One. 2020;15:e0227155.
    PubMed     Abstract available


  55. AHN S, Chung YR, Seo AN, Kim M, et al
    Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    PLoS One. 2020;15:e0233037.
    PubMed     Abstract available


  56. LINDENBERG M, van Beek A, Retel V, van Duijnhoven F, et al
    Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.
    PLoS One. 2020;15:e0232690.
    PubMed     Abstract available


  57. ANDERSON O, Guttilla Reed IK
    Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    PLoS One. 2020;15:e0233187.
    PubMed     Abstract available


  58. STUEBER TN, Diessner J, Bartmann C, Leinert E, et al
    Effect of adjuvant radiotherapy in elderly patients with breast cancer.
    PLoS One. 2020;15:e0229518.
    PubMed     Abstract available


  59. DING Y, Ding K, Yang H, He X, et al
    Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.
    PLoS One. 2020;15:e0234058.
    PubMed     Abstract available


  60. YEERKEN D, Hong R, Wang Y, Gong Y, et al
    PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
    PLoS One. 2020;15:e0233750.
    PubMed     Abstract available


  61. OMASANGGAR R, Yu CY, Ang GY, Emran NA, et al
    Mitochondrial DNA mutations in Malaysian female breast cancer patients.
    PLoS One. 2020;15:e0233461.
    PubMed     Abstract available


  62. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available


  63. ZHENG J, Wu J, Wang C, Zhuang S, et al
    Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233571.
    PubMed     Abstract available


  64. RASMUSSEN GHF, Kristiansen M, Arroyo-Morales M, Voigt M, et al
    Absolute and relative reliability of pain sensitivity and functional outcomes of the affected shoulder among women with pain after breast cancer treatment.
    PLoS One. 2020;15:e0234118.
    PubMed     Abstract available


  65. WONG KK, Hussain FA
    TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
    PLoS One. 2020;15:e0233884.
    PubMed     Abstract available


  66. TRILLA-FUERTES L, Gamez-Pozo A, Arevalillo JM, Lopez-Vacas R, et al
    Bayesian networks established functional differences between breast cancer subtypes.
    PLoS One. 2020;15:e0234752.
    PubMed     Abstract available


  67. DISCALA M, Najor MS, Yung T, Morgan D, et al
    Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
    PLoS One. 2020;15:e0234146.
    PubMed     Abstract available


  68. LABROSSE J, Osdoit M, Hamy AS, Coussy F, et al
    Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.
    PLoS One. 2020;15:e0234173.
    PubMed     Abstract available


  69. MOON HR, Ospina-Munoz N, Noe-Kim V, Yang Y, et al
    Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform.
    PLoS One. 2020;15:e0234012.
    PubMed     Abstract available


  70. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    PubMed     Abstract available


  71. LEE C, Han M, Baek J
    Human observer performance on in-plane digital breast tomosynthesis images: Effects of reconstruction filters and data acquisition angles on signal detection.
    PLoS One. 2020;15:e0229915.
    PubMed     Abstract available


  72. DEMIRCIOGLU A, Grueneisen J, Ingenwerth M, Hoffmann O, et al
    A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
    PLoS One. 2020;15:e0234871.
    PubMed     Abstract available


  73. RAISNER R, Bainer R, Haverty PM, Benedetti KL, et al
    Super-enhancer acquisition drives oncogene expression in triple negative breast cancer.
    PLoS One. 2020;15:e0235343.
    PubMed     Abstract available


  74. OKUMA H, Sudah M, Kettunen T, Niukkanen A, et al
    Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
    PLoS One. 2020;15:e0235278.
    PubMed     Abstract available


  75. BURGUIN A, Furrer D, Ouellette G, Jacob S, et al
    Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0234991.
    PubMed     Abstract available


  76. HAMY AS, Darrigues L, Laas E, De Croze D, et al
    Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.
    PLoS One. 2020;15:e0234191.
    PubMed     Abstract available



  77. Retraction: Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer.
    PLoS One. 2020;15:e0235096.
    PubMed    


  78. NEWTON A, Predina J, Mison M, Runge J, et al
    Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer.
    PLoS One. 2020;15:e0234791.
    PubMed     Abstract available


  79. THIJSSEN B, Wessels LFA
    Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference.
    PLoS One. 2020;15:e0230101.
    PubMed     Abstract available


  80. ARCHER S, Babb de Villiers C, Scheibl F, Carver T, et al
    Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
    PLoS One. 2020;15:e0229999.
    PubMed     Abstract available


  81. TANAKA M, Hsuan C, Oeki M, Shen W, et al
    Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
    PLoS One. 2020;15:e0235442.
    PubMed     Abstract available


  82. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed     Abstract available


  83. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed     Abstract available


  84. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    PubMed     Abstract available


    January 2019
  85. SCHUETZ JM, Grundy A, Lee DG, Lai AS, et al
    Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk.
    PLoS One. 2019;14:e0209010.
    PubMed     Abstract available


  86. LIU M, Yang Y, Xie F, Guo J, et al
    Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?
    PLoS One. 2019;14:e0210437.
    PubMed     Abstract available


  87. LAI YL, Su YC, Kao CH, Liang JA, et al
    Increased risk of varicella-zoster virus infection in patients with breast cancer after adjuvant radiotherapy: A population-based cohort study.
    PLoS One. 2019;14:e0209365.
    PubMed     Abstract available


  88. SHARMA A, Bandyopadhayaya S, Chowdhury K, Sharma T, et al
    Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.
    PLoS One. 2019;14:e0209435.
    PubMed     Abstract available


  89. BONSU AB, Ncama BP
    Recognizing and appraising symptoms of breast cancer as a reason for delayed presentation in Ghanaian women: A qualitative study.
    PLoS One. 2019;14:e0208773.
    PubMed     Abstract available


  90. WATANABE T, Yagata H, Saito M, Okada H, et al
    A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.
    PLoS One. 2019;14:e0208118.
    PubMed     Abstract available


  91. MOUSAVI SA, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, et al
    Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
    PLoS One. 2019;14:e0208701.
    PubMed     Abstract available


  92. MORGAT C, Schollhammer R, Macgrogan G, Barthe N, et al
    Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
    PLoS One. 2019;14:e0210905.
    PubMed     Abstract available


  93. CHATSIPROIOS D, Schmidts-Winkler IM, Konig L, Masur C, et al
    Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    PLoS One. 2019;14:e0210967.
    PubMed     Abstract available


  94. VAN MAAREN MC, Kneepkens RF, Verbaan J, Huijgens PC, et al
    A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
    PLoS One. 2019;14:e0210887.
    PubMed     Abstract available


  95. LAAS E, Hamy AS, Michel AS, Panchbhaya N, et al
    Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach.
    PLoS One. 2019;14:e0208807.
    PubMed     Abstract available


  96. SHOWALTER LE, Oechsle C, Ghimirey N, Steele C, et al
    Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.
    PLoS One. 2019;14:e0210209.
    PubMed     Abstract available



  97. Retraction: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation.
    PLoS One. 2019;14:e0207273.
    PubMed    


  98. KECHAVARZI BD, Wu H, Doman TN
    Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
    PLoS One. 2019;14:e0210910.
    PubMed     Abstract available


  99. CHITAPANARUX I, Nobnop W, Tippanya D, Sripan P, et al
    Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients.
    PLoS One. 2019;14:e0211578.
    PubMed     Abstract available


  100. PIETERS HC, Green E, Khakshooy S, Sleven M, et al
    A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.
    PLoS One. 2019;14:e0210972.
    PubMed     Abstract available


  101. MICHEL LL, Sommer L, Gonzalez Silos R, Lorenzo Bermejo J, et al
    Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
    PLoS One. 2019;14:e0211337.
    PubMed     Abstract available



  102. Expression of Concern: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0211655.
    PubMed    


  103. WILLIAMS LA, Casbas-Hernandez P, Nichols HB, Tse CK, et al
    Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
    PLoS One. 2019;14:e0211488.
    PubMed     Abstract available


  104. HEBERT-MAGEE S, Yu H, Behring M, Jadhav T, et al
    The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
    PLoS One. 2019;14:e0211734.
    PubMed     Abstract available


  105. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0212376.
    PubMed     Abstract available


  106. COLLIN LJ, McCullough LE, Conway K, White AJ, et al
    Reproductive characteristics modify the association between global DNA methylation and breast cancer risk in a population-based sample of women.
    PLoS One. 2019;14:e0210884.
    PubMed     Abstract available


  107. PEARLMAN A, Rahman MT, Upadhyay K, Loke J, et al
    Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.
    PLoS One. 2019;14:e0211737.
    PubMed     Abstract available


  108. MURPHY C, Muscat A, Ashley D, Mukaro V, et al
    Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.
    PLoS One. 2019;14:e0210891.
    PubMed     Abstract available


  109. MEYER SB, Foley K, Olver I, Ward PR, et al
    Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia.
    PLoS One. 2019;14:e0211293.
    PubMed     Abstract available


  110. JIANG X, Wells A, Brufsky A, Neapolitan R, et al
    A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.
    PLoS One. 2019;14:e0213292.
    PubMed     Abstract available


  111. OW SGW, Ong PY, Lee SC
    Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world.
    PLoS One. 2019;14:e0213746.
    PubMed     Abstract available


  112. ROEHRER S, Stork V, Ludwig C, Minceva M, et al
    Analyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics.
    PLoS One. 2019;14:e0213469.
    PubMed     Abstract available


  113. PIOTRZKOWSKA-WROBLEWSKA H, Dobruch-Sobczak K, Klimonda Z, Karwat P, et al
    Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    PLoS One. 2019;14:e0213749.
    PubMed     Abstract available


  114. EGELAND NG, Austdal M, van Diermen-Hidle B, Rewcastle E, et al
    Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
    PLoS One. 2019;14:e0212527.
    PubMed     Abstract available


  115. DUCRET A, James I, Wilson S, Feilke M, et al
    Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.
    PLoS One. 2019;14:e0213892.
    PubMed     Abstract available


  116. WANG H, Xu C, Kong X, Li X, et al
    Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer.
    PLoS One. 2019;14:e0214433.
    PubMed     Abstract available


  117. BONSU AB, Ncama BP
    Integration of breast cancer prevention and early detection into cancer palliative care model.
    PLoS One. 2019;14:e0212806.
    PubMed     Abstract available


  118. VENTURA-ALFARO CE, Avila-Burgos L, Torres-Mejia G
    Adherence of Mexican physicians to clinical guidelines in the management of breast cancer: Effect of the National Catastrophic Health Expenditure Fund.
    PLoS One. 2019;14:e0212841.
    PubMed     Abstract available


  119. HOLMSTROM O, Linder N, Moilanen H, Suutala A, et al
    Detection of breast cancer lymph node metastases in frozen sections with a point-of-care low-cost microscope scanner.
    PLoS One. 2019;14:e0208366.
    PubMed     Abstract available


  120. JIANG Y, Chen L, Zhang H, Xiao X, et al
    Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module.
    PLoS One. 2019;14:e0214587.
    PubMed     Abstract available


  121. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2019;14:e0214826.
    PubMed     Abstract available


  122. ZITO P, Labbozzetta M, Notarbartolo M, Sajeva M, et al
    Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells.
    PLoS One. 2019;14:e0214594.
    PubMed     Abstract available


  123. ZHANG Y, Chen J, Wang Y, Wang D, et al
    Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients.
    PLoS One. 2019;14:e0202311.
    PubMed     Abstract available


  124. BAATJES KJ, Kotze MJ, McCaul M, Conradie M, et al
    Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study.
    PLoS One. 2019;14:e0214153.
    PubMed     Abstract available


  125. SIDDIQUE AB, Ebrahim H, Mohyeldin M, Qusa M, et al
    Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity.
    PLoS One. 2019;14:e0214798.
    PubMed     Abstract available


  126. BURTON LJ, Hawsawi O, Sweeney J, Bowen N, et al
    CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-alpha) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).
    PLoS One. 2019;14:e0214844.
    PubMed     Abstract available


  127. FURUYA Y
    Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system.
    PLoS One. 2019;14:e0215576.
    PubMed     Abstract available


  128. PARE R, Soon PS, Shah A, Lee CS, et al
    Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
    PLoS One. 2019;14:e0214604.
    PubMed     Abstract available


  129. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0216311.
    PubMed     Abstract available


  130. WEN WX, Leong CO
    Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    PLoS One. 2019;14:e0215381.
    PubMed     Abstract available


  131. LOI S, Michiels S, Baselga J, Bartlett JMS, et al
    Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
    PLoS One. 2019;14:e0216175.
    PubMed     Abstract available


  132. NOYAN S, Gurdal H, Gur Dedeoglu B
    Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.
    PLoS One. 2019;14:e0215894.
    PubMed     Abstract available


  133. ADLER G, Kaufman G, Simon-Tuval T
    Healthcare utilization of breast cancer patients following telephone-based consultations of oncology nurse navigator via telemedical care.
    PLoS One. 2019;14:e0216365.
    PubMed     Abstract available


  134. TVEITARAS MK, Selheim F, Sortland K, Reed RK, et al
    Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
    PLoS One. 2019;14:e0215909.
    PubMed     Abstract available


  135. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    PubMed     Abstract available


  136. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2019;14:e0207558.
    PubMed     Abstract available


  137. DIETEL E, Brobeil A, Delventhal L, Tag C, et al
    Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
    PLoS One. 2019;14:e0216642.
    PubMed     Abstract available


  138. WITLOX L, Velthuis MJ, Boer JH, Steins Bisschop CN, et al
    Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.
    PLoS One. 2019;14:e0215517.
    PubMed     Abstract available


  139. UHR K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, et al
    MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
    PLoS One. 2019;14:e0216400.
    PubMed     Abstract available


  140. ZHAO Q, Howard EW, Parris AB, Ma Z, et al
    Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.
    PLoS One. 2019;14:e0216469.
    PubMed     Abstract available


  141. KIM N, Chung W, Eum HH, Lee HO, et al
    Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    PLoS One. 2019;14:e0217196.
    PubMed     Abstract available


  142. ARNOLD M, Pfeifer K, Quante AS
    Is risk-stratified breast cancer screening economically efficient in Germany?
    PLoS One. 2019;14:e0217213.
    PubMed     Abstract available


  143. MONSALVE-LANCHEROS A, Ibanez-Pinilla M, Ramirez-Clavijo S
    Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216989.
    PubMed     Abstract available


  144. ZHANG X, Zhang B, Zhang P, Lian L, et al
    Norcantharidin regulates ERalpha signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    PLoS One. 2019;14:e0217181.
    PubMed     Abstract available


  145. LANDRY AP, Zador Z, Haq R, Cusimano MD, et al
    Reclassification of breast cancer: Towards improved diagnosis and outcome.
    PLoS One. 2019;14:e0217036.
    PubMed     Abstract available


  146. KUROZUMI S, Yamaguchi Y, Matsumoto H, Kurosumi M, et al
    Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.
    PLoS One. 2019;14:e0217279.
    PubMed     Abstract available


  147. SALES-DIAS J, Silva G, Lamy M, Ferreira A, et al
    The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.
    PLoS One. 2019;14:e0217002.
    PubMed     Abstract available


  148. SALEH ME, Gadalla R, Hassan H, Afifi A, et al
    The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
    PLoS One. 2019;14:e0217550.
    PubMed     Abstract available


  149. RATH M, Li Q, Li H, Lindstrom S, et al
    Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
    PLoS One. 2019;14:e0216997.
    PubMed     Abstract available


  150. HAJJAR A, Ergun MA, Alagoz O, Rampurwala M, et al
    Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer.
    PLoS One. 2019;14:e0217778.
    PubMed     Abstract available



  151. Expression of Concern: Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines.
    PLoS One. 2019;14:e0217961.
    PubMed    


  152. FULTANG N, Illendula A, Chen B, Wu C, et al
    Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ss activity.
    PLoS One. 2019;14:e0217789.
    PubMed     Abstract available


  153. ESPLUGAS R, Arenas M, Serra N, Belles M, et al
    Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
    PLoS One. 2019;14:e0217443.
    PubMed     Abstract available


  154. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0218030.
    PubMed     Abstract available


  155. SHARP JW, Hippe DS, Nakigudde G, Anderson BO, et al
    Modifiable patient-related barriers and their association with breast cancer detection practices among Ugandan women without a diagnosis of breast cancer.
    PLoS One. 2019;14:e0217938.
    PubMed     Abstract available


  156. JUNG SY, Mancuso N, Papp J, Sobel E, et al
    Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
    PLoS One. 2019;14:e0218917.
    PubMed     Abstract available


  157. WESSELS DJ, Pradhan N, Park YN, Klepitsch MA, et al
    Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment.
    PLoS One. 2019;14:e0218854.
    PubMed     Abstract available


  158. EKDAHL HJELM T, Matovu A, Mugisha N, Lofgren J, et al
    Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer.
    PLoS One. 2019;14:e0219601.
    PubMed     Abstract available



  159. Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    PLoS One. 2019;14:e0219887.
    PubMed    


  160. STUR E, Aristizabal-Pachon AF, Peronni KC, Agostini LP, et al
    Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines.
    PLoS One. 2019;14:e0219610.
    PubMed     Abstract available


  161. IMRAN M, Al-Wassia R, Alkhayyat SS, Baig M, et al
    Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    PLoS One. 2019;14:e0219093.
    PubMed     Abstract available


  162. HEQUET D, Huchon C, Soilly AL, Asselain B, et al
    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
    PLoS One. 2019;14:e0210917.
    PubMed     Abstract available


  163. HERR D, Wischnewsky M, Joukhadar R, Chow O, et al
    Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study.
    PLoS One. 2019;14:e0218434.
    PubMed     Abstract available


  164. TERAVA J, Tiainen L, Lamminmaki U, Kellokumpu-Lehtinen PL, et al
    Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
    PLoS One. 2019;14:e0219480.
    PubMed     Abstract available


  165. GEBREMARIAM A, Addissie A, Worku A, Assefa M, et al
    Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study.
    PLoS One. 2019;14:e0220769.
    PubMed     Abstract available


  166. SARKAR A, Chanda A, Regmi SC, Karve K, et al
    Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFbeta-Hyaluronan-CD44 signalling pathway.
    PLoS One. 2019;14:e0219697.
    PubMed     Abstract available



  167. Expression of Concern: Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression.
    PLoS One. 2019;14:e0220672.
    PubMed    


  168. DI COSIMO S, La Verde N, Moretti A, Cazzaniga ME, et al
    Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
    PLoS One. 2019;14:e0220644.
    PubMed     Abstract available


  169. POULADI N, Abdolahi S, Farajzadeh D, Hosseinpour Feizi MA, et al
    Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
    PLoS One. 2019;14:e0220727.
    PubMed     Abstract available


  170. WANG L, Xiao Y, Ping Y, Li J, et al
    Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer.
    PLoS One. 2019;14:e0221483.
    PubMed     Abstract available


  171. BADGUJAR NV, Tarapara BV, Shah FD
    Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
    PLoS One. 2019;14:e0220711.
    PubMed     Abstract available


  172. AMIRFALLAH A, Arason A, Einarsson H, Gudmundsdottir ET, et al
    High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
    PLoS One. 2019;14:e0221413.
    PubMed     Abstract available


  173. CLEMENT-ZHAO A, Tanguy ML, Cottu P, De La Lande B, et al
    Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
    PLoS One. 2019;14:e0221816.
    PubMed     Abstract available


  174. TIAN W, Yao Y, Fan G, Zhou Y, et al
    Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study.
    PLoS One. 2019;14:e0221866.
    PubMed     Abstract available


  175. YOON CI, Ahn SG, Bae SJ, Shin YJ, et al
    High A20 expression negatively impacts survival in patients with breast cancer.
    PLoS One. 2019;14:e0221721.
    PubMed     Abstract available


  176. SCHAFFAR R, Bouchardy C, Chappuis PO, Bodmer A, et al
    A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland.
    PLoS One. 2019;14:e0222136.
    PubMed     Abstract available


  177. ABDEL-FATTAH M, Saeed H, El-Shennawy L, Shalaby M, et al
    The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines.
    PLoS One. 2019;14:e0213880.
    PubMed     Abstract available


  178. LU Y, Zhang L, Zhang Q, Zhang Y, et al
    The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0221374.
    PubMed     Abstract available


  179. SATOMI-TSUSHITA N, Shimomura A, Matsuzaki J, Yamamoto Y, et al
    Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer.
    PLoS One. 2019;14:e0222024.
    PubMed     Abstract available


  180. BROUWER A, De Laere B, van Dam PJ, Peeters D, et al
    HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
    PLoS One. 2019;14:e0220906.
    PubMed     Abstract available


  181. ELBASHEER MMA, Alkhidir AGA, Mohammed SMA, Abbas AAH, et al
    Spatial distribution of breast cancer in Sudan 2010-2016.
    PLoS One. 2019;14:e0211085.
    PubMed     Abstract available


  182. HASSEN AM, Taye G, Gizaw M, Hussien FM, et al
    Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0222629.
    PubMed     Abstract available


  183. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    PubMed     Abstract available


  184. MUNOZ R, Hileeto D, Cruz-Munoz W, Wood GA, et al
    Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
    PLoS One. 2019;14:e0222580.
    PubMed     Abstract available


  185. BAGEGNI NA, Tao Y, Ademuyiwa FO
    Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
    PLoS One. 2019;14:e0222358.
    PubMed     Abstract available


  186. FUNAKOSHI Y, Wang Y, Semba T, Masuda H, et al
    Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    PLoS One. 2019;14:e0222336.
    PubMed     Abstract available


  187. JUNG KH, Lee EJ, Park JW, Lee JH, et al
    EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
    PLoS One. 2019;14:e0221294.
    PubMed     Abstract available


  188. LI Y, Giorgi EE, Beckman KB, Caberto C, et al
    Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.
    PLoS One. 2019;14:e0222284.
    PubMed     Abstract available


  189. HALASZ LM, Patel SA, McDougall JA, Fedorenko C, et al
    Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
    PLoS One. 2019;14:e0222904.
    PubMed     Abstract available


  190. CHIGNOLA R, Sega M, Molesini B, Baruzzi A, et al
    Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein.
    PLoS One. 2019;14:e0206713.
    PubMed     Abstract available


  191. WINSLOW S, Scholz A, Rappl P, Brauss TF, et al
    Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation.
    PLoS One. 2019;14:e0209694.
    PubMed     Abstract available


  192. LEE KJ, Piett CG, Andrews JF, Mann E, et al
    Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.
    PLoS One. 2019;14:e0223725.
    PubMed     Abstract available


  193. ZHAI Q, Fan J, Lin Q, Liu X, et al
    Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.
    PLoS One. 2019;14:e0223325.
    PubMed     Abstract available


  194. DE LEMOS LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, et al
    Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0224012.
    PubMed     Abstract available


  195. SANTOYO-OLSSON J, Stewart AL, Samayoa C, Palomino H, et al
    Translating a stress management intervention for rural Latina breast cancer survivors: The Nuevo Amanecer-II.
    PLoS One. 2019;14:e0224068.
    PubMed     Abstract available


  196. SATO J, Shimomura A, Kawauchi J, Matsuzaki J, et al
    Brain metastasis-related microRNAs in patients with advanced breast cancer.
    PLoS One. 2019;14:e0221538.
    PubMed     Abstract available


  197. HILL DA, Prossnitz ER, Royce M, Nibbe A, et al
    Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.
    PLoS One. 2019;14:e0224064.
    PubMed     Abstract available


  198. COWPPLI-BONY A, Tretarre B, Marrer E, Defossez G, et al
    Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
    PLoS One. 2019;14:e0224275.
    PubMed     Abstract available


  199. CHENG W, Shen X, Xing M
    Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0221093.
    PubMed     Abstract available


  200. KIM HJ, Park JY, Lee TS, Song IH, et al
    PET imaging of HER2 expression with an 18F-fluoride labeled aptamer.
    PLoS One. 2019;14:e0211047.
    PubMed     Abstract available


  201. OLIVIER M, Bouaoun L, Villar S, Robitaille A, et al
    Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study.
    PLoS One. 2019;14:e0210372.
    PubMed     Abstract available


  202. DELGADO R, Nunez-Gonzalez JD
    Enhancing Confusion Entropy (CEN) for binary and multiclass classification.
    PLoS One. 2019;14:e0210264.
    PubMed     Abstract available


  203. TAVAKOLI TABA S, Brennan PC, Lewis S
    Dynamics of breast imaging research: A global scoping review and Sino-Australian comparison case study.
    PLoS One. 2019;14:e0210256.
    PubMed     Abstract available


  204. HELLERHOFF K, Birnbacher L, Sztrokay-Gaul A, Grandl S, et al
    Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study.
    PLoS One. 2019;14:e0210291.
    PubMed     Abstract available


  205. FOKIALAKIS N, Alexi X, Aligiannis N, Boulaka A, et al
    Biological evaluation of isoflavonoids from Genista halacsyi using estrogen-target cells: Activities of glucosides compared to aglycones.
    PLoS One. 2019;14:e0210247.
    PubMed     Abstract available


  206. MANDRIK O, Yaumenenka A, Herrero R, Jonker MF, et al
    Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus.
    PLoS One. 2019;14:e0224667.
    PubMed     Abstract available


  207. MENDONCA P, Horton A, Bauer D, Messeha S, et al
    The inhibitory effects of butein on cell proliferation and TNF-alpha-induced CCL2 release in racially different triple negative breast cancer cells.
    PLoS One. 2019;14:e0215269.
    PubMed     Abstract available


  208. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Abstract available


  209. HUANG YH, Lee MS, Lou YS, Lai HC, et al
    Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.
    PLoS One. 2019;14:e0224728.
    PubMed     Abstract available


  210. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    PubMed     Abstract available


  211. AFKHAMI M, Schmolze D, Yost SE, Frankel PH, et al
    Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
    PLoS One. 2019;14:e0224726.
    PubMed     Abstract available


  212. HEDAYATI E, Fracheboud L, Srikant V, Greber D, et al
    Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden.
    PLoS One. 2019;14:e0211783.
    PubMed     Abstract available


  213. MINAMI Y, Kanemura S, Kawai M, Nishino Y, et al
    Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.
    PLoS One. 2019;14:e0224797.
    PubMed     Abstract available


  214. MREMI A, Broadwater G, Jackson K, Amsi P, et al
    Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.
    PLoS One. 2019;14:e0224760.
    PubMed     Abstract available


  215. TERRAZZINO S, Cargnin S, Deantonio L, Pisani C, et al
    Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis.
    PLoS One. 2019;14:e0225685.
    PubMed     Abstract available


  216. GIORDANO A, Liu Y, Armeson K, Park Y, et al
    Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.
    PLoS One. 2019;14:e0224420.
    PubMed     Abstract available


  217. SSENTONGO P, Lewcun JA, Candela X, Ssentongo AE, et al
    Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225039.
    PubMed     Abstract available


  218. REDMOND AM, Omarjee S, Chernukhin I, Le Romancer M, et al
    Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.
    PLoS One. 2019;14:e0225180.
    PubMed     Abstract available


  219. LJEPOJA B, Schreiber C, Gegenfurtner FA, Garcia-Roman J, et al
    Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.
    PLoS One. 2019;14:e0224314.
    PubMed     Abstract available


  220. CATTEAU X, Simon P, Jondet M, Vanhaeverbeek M, et al
    Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
    PLoS One. 2019;14:e0210263.
    PubMed     Abstract available


  221. CHENG W, Shen X, Xing M
    Correction: Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0225986.
    PubMed     Abstract available


  222. RUPJI M, Dwivedi B, Kowalski J
    NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    PLoS One. 2019;14:e0204542.
    PubMed     Abstract available


  223. FORGET P, Bouche G, Duhoux FP, Coulie PG, et al
    Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial.
    PLoS One. 2019;14:e0225748.
    PubMed     Abstract available


  224. TETEH D, Ericson M, Monice S, Dawkins-Moultin L, et al
    The Black identity, hair product use, and breast cancer scale.
    PLoS One. 2019;14:e0225305.
    PubMed     Abstract available


  225. PARK J, Shin Y, Kim TH, Kim DH, et al
    Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
    PLoS One. 2019;14:e0225129.
    PubMed     Abstract available


  226. YOO B, Meka N, Sheedy P, Billig AM, et al
    MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
    PLoS One. 2019;14:e0226356.
    PubMed     Abstract available



  227. Retraction: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0226703.
    PubMed    


  228. WEN W, Xuan D, Hu Y, Li X, et al
    Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225959.
    PubMed     Abstract available


  229. JOGI A, Ehinger A, Hartman L, Alkner S, et al
    Expression of HIF-1alpha is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
    PLoS One. 2019;14:e0226150.
    PubMed     Abstract available


  230. PARK HS, Lee JD, Kim JY, Park S, et al
    Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
    PLoS One. 2019;14:e0225082.
    PubMed     Abstract available


  231. ROMAN M, Sala M, Domingo L, Posso M, et al
    Personalized breast cancer screening strategies: A systematic review and quality assessment.
    PLoS One. 2019;14:e0226352.
    PubMed     Abstract available


  232. TALMONT F, Mouledous L, Baranger M, Gomez-Brouchet A, et al
    Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.
    PLoS One. 2019;14:e0213203.
    PubMed     Abstract available


  233. STARK GF, Hart GR, Nartowt BJ, Deng J, et al
    Predicting breast cancer risk using personal health data and machine learning models.
    PLoS One. 2019;14:e0226765.
    PubMed     Abstract available


  234. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0227068.
    PubMed     Abstract available


  235. JIANG Y, Weinberg CR, Sandler DP, Zhao S, et al
    Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
    PLoS One. 2019;14:e0226407.
    PubMed     Abstract available


  236. LEE SJ, Sim TS, Shin HY, Lee J, et al
    Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.
    PLoS One. 2019;14:e0223193.
    PubMed     Abstract available


  237. SHETH M, Gerovitch A, Welsch R, Markuzon N, et al
    The Univariate Flagging Algorithm (UFA): An interpretable approach for predictive modeling.
    PLoS One. 2019;14:e0223161.
    PubMed     Abstract available


  238. HECK L, Dierolf M, Jud C, Eggl E, et al
    Contrast-enhanced spectral mammography with a compact synchrotron source.
    PLoS One. 2019;14:e0222816.
    PubMed     Abstract available


  239. WU WP, Wu HK, Chen CJ, Lee CW, et al
    Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
    PLoS One. 2019;14:e0222917.
    PubMed     Abstract available


  240. ABECASSIS J, Hamy AS, Laurent C, Sadacca B, et al
    Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    PLoS One. 2019;14:e0224143.
    PubMed     Abstract available


  241. SHON EJ, Townsend AL
    Predictors of never having a mammogram among Chinese, Vietnamese, and Korean immigrant women in the U.S.
    PLoS One. 2019;14:e0224505.
    PubMed     Abstract available


  242. YLOSMAKI L, Polini B, Carpi S, Martins B, et al
    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
    PLoS One. 2019;14:e0224072.
    PubMed     Abstract available


  243. PETROVIC K, Robinson J, Whitworth K, Jinks E, et al
    TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo.
    PLoS One. 2019;14:e0224015.
    PubMed     Abstract available


  244. IWATA TN, Sugihara K, Wada T, Agatsuma T, et al
    [Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti-CTLA-4 antibody in a mouse model.
    PLoS One. 2019;14:e0222280.
    PubMed     Abstract available


  245. ALHAKAMY NA, Fahmy UA, Ahmed OAA
    Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene.
    PLoS One. 2019;14:e0226639.
    PubMed     Abstract available


  246. NAKAMOTO S, Hirose M
    Prediction of early C-reactive protein levels after non-cardiac surgery under general anesthesia.
    PLoS One. 2019;14:e0226032.
    PubMed     Abstract available


    January 2018
  247. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    PubMed     Abstract available


  248. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    PubMed     Abstract available


  249. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    PubMed     Abstract available


  250. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    PubMed     Abstract available


  251. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    PubMed     Abstract available


  252. BROMBERG SE, Moraes PRAF, Ades F
    Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0191056.
    PubMed     Abstract available


  253. HILDENBRAND G, Metzler P, Pilarczyk G, Bobu V, et al
    Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.
    PLoS One. 2018;13:e0190183.
    PubMed     Abstract available


  254. LI T, Zhao J, Yang J, Ma X, et al
    Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2018;13:e0191579.
    PubMed     Abstract available


  255. KHALIS M, Charbotel B, Chajes V, Rinaldi S, et al
    Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco.
    PLoS One. 2018;13:e0191333.
    PubMed     Abstract available


  256. TSAI HP, Huang SF, Li CF, Chien HT, et al
    Differential microRNA expression in breast cancer with different onset age.
    PLoS One. 2018;13:e0191195.
    PubMed     Abstract available


  257. SYED BM, Morgan D, Setty T, Green AR, et al
    Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2018;13:e0191979.
    PubMed     Abstract available


  258. KIM J, Choi SH, Ham SJ, Cho YC, et al
    Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    PLoS One. 2018;13:e0187063.
    PubMed     Abstract available


  259. BOUGARET L, Delort L, Billard H, Le Huede C, et al
    Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
    PLoS One. 2018;13:e0191571.
    PubMed     Abstract available


  260. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Abstract available


  261. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    PubMed     Abstract available


  262. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    PubMed     Abstract available


  263. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    PubMed     Abstract available


  264. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    PubMed     Abstract available


  265. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    PubMed     Abstract available


  266. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    PubMed     Abstract available


  267. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    PubMed     Abstract available


  268. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    PubMed     Abstract available


  269. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    PubMed     Abstract available


  270. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    PubMed     Abstract available


  271. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    PubMed     Abstract available


  272. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Abstract available


  273. HO PJ, Hartman M, Young-Afat DA, Gernaat SAM, et al
    Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study.
    PLoS One. 2018;13:e0193099.
    PubMed     Abstract available


  274. JENSEN-JOHANSEN MB, O'Toole MS, Christensen S, Valdimarsdottir H, et al
    Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.
    PLoS One. 2018;13:e0192729.
    PubMed     Abstract available


  275. DE GROEF A, Van Kampen M, Moortgat P, Anthonissen M, et al
    An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity.
    PLoS One. 2018;13:e0193915.
    PubMed     Abstract available


  276. BOSE C, Awasthi S, Sharma R, Benes H, et al
    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
    PLoS One. 2018;13:e0193918.
    PubMed     Abstract available


  277. HUSSAIN A, Yong C, Tkaczuk KHR, Qian Y, et al
    Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    PLoS One. 2018;13:e0193661.
    PubMed     Abstract available


  278. ALMOTWAA S, Elrobh M, AbdulKarim H, Alanazi M, et al
    Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    PLoS One. 2018;13:e0193095.
    PubMed     Abstract available


  279. VREEMANN S, Gubern-Merida A, Borelli C, Bult P, et al
    The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    PLoS One. 2018;13:e0191399.
    PubMed     Abstract available


  280. LAGUNIN AA, Dubovskaja VI, Rudik AV, Pogodin PV, et al
    CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.
    PLoS One. 2018;13:e0191838.
    PubMed     Abstract available


  281. ZHAO X, Wei J, Li X, Yang H, et al
    Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.
    PLoS One. 2018;13:e0193784.
    PubMed     Abstract available


  282. HELLEC C, Delos M, Carpentier M, Denys A, et al
    The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
    PLoS One. 2018;13:e0194676.
    PubMed     Abstract available


  283. MAHMUD A, Aljunid SM
    Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach.
    PLoS One. 2018;13:e0191764.
    PubMed     Abstract available


  284. DVORAK KM, Pettee KM, Rubinic-Minotti K, Su R, et al
    Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
    PLoS One. 2018;13:e0195278.
    PubMed     Abstract available


  285. ARYAL B, Rao VA
    Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.
    PLoS One. 2018;13:e0194164.
    PubMed     Abstract available


  286. TAMEZ-PENA JG, Rodriguez-Rojas JA, Gomez-Rueda H, Celaya-Padilla JM, et al
    Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.
    PLoS One. 2018;13:e0193871.
    PubMed     Abstract available


  287. KHAJAH MA, Mathew PM, Luqmani YA
    Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.
    PLoS One. 2018;13:e0193779.
    PubMed     Abstract available


  288. NGUYEN CP, Adang EMM
    Cost-effectiveness of breast cancer screening using mammography in Vietnamese women.
    PLoS One. 2018;13:e0194996.
    PubMed     Abstract available


  289. BROMBERG SE, Moraes PRAF, Ades F
    Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0195130.
    PubMed     Abstract available


  290. LUENGO-GIL G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, et al
    Angiogenic role of miR-20a in breast cancer.
    PLoS One. 2018;13:e0194638.
    PubMed     Abstract available


  291. BAMBHROLIYA A, Van Wyhe RD, Kumar S, Debeb BG, et al
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    PLoS One. 2018;13:e0192689.
    PubMed     Abstract available


  292. HAN Q, Chen R, Wang F, Chen S, et al
    Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    PLoS One. 2018;13:e0192888.
    PubMed     Abstract available


  293. LUCHSINGER C, Aguilar M, Burgos PV, Ehrenfeld P, et al
    Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    PLoS One. 2018;13:e0195401.
    PubMed     Abstract available


  294. HORIBATA S, Rice EJ, Zheng H, Mukai C, et al
    A bi-stable feedback loop between GDNF, EGR1, and ERalpha contribute to endocrine resistant breast cancer.
    PLoS One. 2018;13:e0194522.
    PubMed     Abstract available


  295. HORIBATA S, Rice EJ, Mukai C, Marks BA, et al
    ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    PLoS One. 2018;13:e0194023.
    PubMed     Abstract available


  296. NAM SY, Ko ES, Lim Y, Han BK, et al
    Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    PLoS One. 2018;13:e0195756.
    PubMed     Abstract available


  297. CHU LW, John EM, Yang B, Kurian AW, et al
    Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
    PLoS One. 2018;13:e0195666.
    PubMed     Abstract available


  298. SANDLIN RD, Wong KHK, Tessier SN, Swei A, et al
    Ultra-fast vitrification of patient-derived circulating tumor cell lines.
    PLoS One. 2018;13:e0192734.
    PubMed     Abstract available


  299. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Abstract available


  300. KORONOWICZ AA, Drozdowska M, Wielgos B, Piasna-Slupecka E, et al
    The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.
    PLoS One. 2018;13:e0192860.
    PubMed     Abstract available


  301. DEWALD JH, Cavdarli S, Steenackers A, Delannoy CP, et al
    TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    PLoS One. 2018;13:e0196369.
    PubMed     Abstract available


  302. PARISE C, Caggiano V
    The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    PLoS One. 2018;13:e0196134.
    PubMed     Abstract available


  303. TISSIER R, Houwing-Duistermaat J, Rodriguez-Girondo M
    Improving stability of prediction models based on correlated omics data by using network approaches.
    PLoS One. 2018;13:e0192853.
    PubMed     Abstract available


  304. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Abstract available


  305. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    PubMed     Abstract available


  306. KOVAC B, Makela TP, Vallenius T
    Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    PLoS One. 2018;13:e0196986.
    PubMed     Abstract available


  307. SENARAS C, Niazi MKK, Sahiner B, Pennell MP, et al
    Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
    PLoS One. 2018;13:e0196846.
    PubMed     Abstract available


  308. FATIMA I, El-Ayachi I, Taotao L, Angeles Lillo M, et al
    Correction: The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2018;13:e0197796.
    PubMed     Abstract available


  309. ECKHARDT BL, Gagliardi M, Iles L, Evans K, et al
    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
    PLoS One. 2018;13:e0195932.
    PubMed     Abstract available


  310. LIM ST, Park CH, Kim SY, Nam SJ, et al
    The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.
    PLoS One. 2018;13:e0197523.
    PubMed     Abstract available


  311. ZENG Z, Jiang X, Li X, Wells A, et al
    Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    PLoS One. 2018;13:e0197064.
    PubMed     Abstract available


  312. KHARMAN-BIZ A, Gao H, Ghiasvand R, Haldosen LA, et al
    Expression of the three components of linear ubiquitin assembly complex in breast cancer.
    PLoS One. 2018;13:e0197183.
    PubMed     Abstract available


  313. RACCAGNI I, Belloli S, Valtorta S, Stefano A, et al
    [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PLoS One. 2018;13:e0197754.
    PubMed     Abstract available



  314. Retraction: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies.
    PLoS One. 2018;13:e0198220.
    PubMed    


  315. STRUIK GM, Vrijland WW, Birnie E, Klem TMAL, et al
    A randomized controlled trial on the effect of a silver carboxymethylcellulose dressing on surgical site infections after breast cancer surgery.
    PLoS One. 2018;13:e0195715.
    PubMed     Abstract available


  316. HUBBELING HG, Rosenberg SM, Gonzalez-Robledo MC, Cohn JG, et al
    Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.
    PLoS One. 2018;13:e0197931.
    PubMed     Abstract available


  317. PAVANELLO S, Varesco L, Gismondi V, Bruzzi P, et al
    Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    PLoS One. 2018;13:e0197522.
    PubMed     Abstract available


  318. RAINEY L, van der Waal D, Donnelly LS, Evans DG, et al
    Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
    PLoS One. 2018;13:e0197772.
    PubMed     Abstract available


  319. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0198017.
    PubMed     Abstract available


  320. GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    PLoS One. 2018;13:e0198143.
    PubMed     Abstract available


  321. VEYS I, Pop CF, Barbieux R, Moreau M, et al
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    PLoS One. 2018;13:e0197857.
    PubMed     Abstract available


  322. ALHAMAMI M, Cheng W, Lyu Y, Allen C, et al
    Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0196998.
    PubMed     Abstract available


  323. CRUZ-ROA A, Gilmore H, Basavanhally A, Feldman M, et al
    High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
    PLoS One. 2018;13:e0196828.
    PubMed     Abstract available


  324. GU S, Ngamcherdtrakul W, Reda M, Hu Z, et al
    Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
    PLoS One. 2018;13:e0198141.
    PubMed     Abstract available


  325. FORMA E, Jozwiak P, Ciesielski P, Zaczek A, et al
    Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    PLoS One. 2018;13:e0198351.
    PubMed     Abstract available


  326. HAN X, Zhao J, Ruddy KJ, Lin CC, et al
    The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.
    PLoS One. 2018;13:e0198771.
    PubMed     Abstract available


  327. ASTVATSATURYAN K, Yue Y, Walts AE, Bose S, et al
    Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
    PLoS One. 2018;13:e0197827.
    PubMed     Abstract available


  328. ALI S, Malik MZ, Singh SS, Chirom K, et al
    Exploring novel key regulators in breast cancer network.
    PLoS One. 2018;13:e0198525.
    PubMed     Abstract available


  329. EASTLACK SC, Dong S, Mo YY, Alahari SK, et al
    Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
    PLoS One. 2018;13:e0198945.
    PubMed     Abstract available


  330. MCDONNELL SL, Baggerly CA, French CB, Baggerly LL, et al
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    PLoS One. 2018;13:e0199265.
    PubMed     Abstract available


  331. HENRY TR, Marshall SA, Avis NE, Levine BJ, et al
    Concordance networks and application to clustering cancer symptomology.
    PLoS One. 2018;13:e0191981.
    PubMed     Abstract available


  332. LESICKA M, Jablonska E, Wieczorek E, Seroczynska B, et al
    Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
    PLoS One. 2018;13:e0199622.
    PubMed     Abstract available


  333. BOYNE DJ, King WD, Brenner DR, McIntyre JB, et al
    Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial.
    PLoS One. 2018;13:e0198641.
    PubMed     Abstract available


  334. LOBBA ARM, Carreira ACO, Cerqueira OLD, Fujita A, et al
    High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
    PLoS One. 2018;13:e0199254.
    PubMed     Abstract available


  335. MARTIN CL, Tate DF, Valle CG
    Nonadherence to daily self-weighing and activity tracking is associated with weight fluctuations among African American breast cancer survivors.
    PLoS One. 2018;13:e0199751.
    PubMed     Abstract available


  336. VOUTOURI C, Stylianopoulos T
    Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    PLoS One. 2018;13:e0193801.
    PubMed     Abstract available


  337. HORIE Y, Makihara H, Horikawa K, Takeshige F, et al
    Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.
    PLoS One. 2018;13:e0193830.
    PubMed     Abstract available


  338. GODLEWSKA M, Krasuska W, Czarnocka B
    Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.
    PLoS One. 2018;13:e0193624.
    PubMed     Abstract available


  339. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2018;13:e0199012.
    PubMed     Abstract available


  340. CHEN Z, Ai L, Mboge MY, Tu C, et al
    Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2018;13:e0199476.
    PubMed     Abstract available


  341. TAKABAYASHI M, Majeed H, Kajdacsy-Balla A, Popescu G, et al
    Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.
    PLoS One. 2018;13:e0194320.
    PubMed     Abstract available


  342. CHOI SW, Ryu SY, Han MA, Park J, et al
    Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis?
    PLoS One. 2018;13:e0200484.
    PubMed     Abstract available


  343. KIM YY, Oh SJ, Chun YS, Lee WK, et al
    Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
    PLoS One. 2018;13:e0200100.
    PubMed     Abstract available


  344. TYURYUMINA EY, Neznanov AA
    Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
    PLoS One. 2018;13:e0200148.
    PubMed     Abstract available


  345. SUN X, Stewart DA, Sandhu R, Kirk EL, et al
    Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    PLoS One. 2018;13:e0193792.
    PubMed     Abstract available


  346. BINDER K, Krauss S, Bruckmaier G, Marienhagen J, et al
    Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making.
    PLoS One. 2018;13:e0195029.
    PubMed     Abstract available


  347. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Abstract available


  348. SETYOWIBOWO H, Purba FD, Hunfeld JAM, Iskandarsyah A, et al
    Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general.
    PLoS One. 2018;13:e0200966.
    PubMed     Abstract available


  349. DEPARDON E, Kanoun S, Humbert O, Bertaut A, et al
    FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    PLoS One. 2018;13:e0199529.
    PubMed     Abstract available


  350. MITCHELL R, Buckingham L, Cobleigh M, Rotmensch J, et al
    Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
    PLoS One. 2018;13:e0195497.
    PubMed     Abstract available


  351. PETURSSON HI, Kovacs A, Mattsson J, Olofsson Bagge R, et al
    Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.
    PLoS One. 2018;13:e0195560.
    PubMed     Abstract available


  352. AL-AJMI K, Lophatananon A, Ollier W, Muir KR, et al
    Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.
    PLoS One. 2018;13:e0201097.
    PubMed     Abstract available


  353. CHO U, Park HS, Im SY, Yoo CY, et al
    Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    PLoS One. 2018;13:e0200936.
    PubMed     Abstract available


  354. GUO J, Liu C, Wang W, Liu Y, et al
    Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    PLoS One. 2018;13:e0200716.
    PubMed     Abstract available


  355. DANIELS B, Girosi F, Tervonen H, Kiely BE, et al
    Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016).
    PLoS One. 2018;13:e0198152.
    PubMed     Abstract available


  356. HILTON J, Stober C, Mazzarello S, Vandermeer L, et al
    Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
    PLoS One. 2018;13:e0199297.
    PubMed     Abstract available


  357. KASSARDJIAN A, Shintaku PI, Moatamed NA
    Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    PLoS One. 2018;13:e0195958.
    PubMed     Abstract available


  358. GOUSSIA A, Simou N, Zagouri F, Manousou K, et al
    Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    PLoS One. 2018;13:e0200302.
    PubMed     Abstract available


  359. MESSEHA SS, Zarmouh NO, Mendonca P, Alwagdani H, et al
    The inhibitory effects of plumbagin on the NF-B pathway and CCL2 release in racially different triple-negative breast cancer cells.
    PLoS One. 2018;13:e0201116.
    PubMed     Abstract available


  360. SAEUI CT, Nairn AV, Galizzi M, Douville C, et al
    Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    PLoS One. 2018;13:e0195812.
    PubMed     Abstract available


  361. OGATA H, Mitsuzuka Y, Honma N, Yoshida M, et al
    Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions.
    PLoS One. 2018;13:e0197156.
    PubMed     Abstract available


  362. KUMAR V, Webb JM, Gregory A, Denis M, et al
    Automated and real-time segmentation of suspicious breast masses using convolutional neural network.
    PLoS One. 2018;13:e0195816.
    PubMed     Abstract available


  363. TSAI CW, Chang WS, Shen TC, Su CH, et al
    Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk.
    PLoS One. 2018;13:e0202112.
    PubMed     Abstract available



  364. Retraction: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    PLoS One. 2018;13:e0202299.
    PubMed    


  365. LI X, Rouchka EC, Brock GN, Yan J, et al
    A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
    PLoS One. 2018;13:e0201813.
    PubMed     Abstract available


  366. UDDIN MM, Zou Y, Sharma T, Gatla HR, et al
    Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy.
    PLoS One. 2018;13:e0201858.
    PubMed     Abstract available


  367. BANNOUD N, Carvelli FL, Troncoso M, Sartor T, et al
    Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0201844.
    PubMed     Abstract available


  368. KUROZUMI S, Matsumoto H, Inoue K, Tozuka K, et al
    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    PLoS One. 2018;13:e0201846.
    PubMed     Abstract available


  369. COTE D, Eustace A, Toomey S, Cremona M, et al
    Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).
    PLoS One. 2018;13:e0200996.
    PubMed     Abstract available


  370. FIGUEIREDO FWDS, Almeida TCDC, Schoueri JHM, Luisi C, et al
    Association between primary care coverage and breast cancer mortality in Brazil.
    PLoS One. 2018;13:e0200125.
    PubMed     Abstract available



  371. Retraction: Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERalpha-Positive Breast Cancer Cells on Hard Substrates.
    PLoS One. 2018;13:e0202617.
    PubMed    


  372. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Fernandez-Navarro P, et al
    Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.
    PLoS One. 2018;13:e0201750.
    PubMed     Abstract available


  373. KHALID S, Hanif R, Jabeen I, Mansoor Q, et al
    Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
    PLoS One. 2018;13:e0196312.
    PubMed     Abstract available


  374. IPPOLITO E, Fiore M, Di Donato A, Silipigni S, et al
    Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.
    PLoS One. 2018;13:e0195506.
    PubMed     Abstract available


  375. GOMES RS, Moreira FTC, Fernandes R, Sales MGF, et al
    Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes.
    PLoS One. 2018;13:e0196656.
    PubMed     Abstract available


  376. TARIQ H, Eldridge E, Welch I
    An efficient approach for feature construction of high-dimensional microarray data by random projections.
    PLoS One. 2018;13:e0196385.
    PubMed     Abstract available


  377. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Abstract available


  378. YANG J, Min KW, Kim DH, Son BK, et al
    High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    PLoS One. 2018;13:e0202113.
    PubMed     Abstract available


  379. CARIOU A, Rouzier R, Baffert S, Soilly AL, et al
    Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.
    PLoS One. 2018;13:e0202385.
    PubMed     Abstract available


  380. RANASINGHE SL, Boyle GM, Fischer K, Potriquet J, et al
    Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.
    PLoS One. 2018;13:e0200433.
    PubMed     Abstract available


  381. COBO-CUENCA AI, Martin-Espinosa NM, Sampietro-Crespo A, Rodriguez-Borrego MA, et al
    Sexual dysfunction in Spanish women with breast cancer.
    PLoS One. 2018;13:e0203151.
    PubMed     Abstract available


  382. SMITH A, Mullooly M, Murphy L, Barron TI, et al
    Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2018;13:e0202291.
    PubMed     Abstract available


  383. KOUSSEMOU M, Lorenz K, Klotz KN
    The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1.
    PLoS One. 2018;13:e0202914.
    PubMed     Abstract available


  384. BLACKBURN NE, Mc Veigh JG, Mc Caughan EM, Kennedy RD, et al
    The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer.
    PLoS One. 2018;13:e0202859.
    PubMed     Abstract available


  385. SCIOLI MG, Artuso S, D'Angelo C, Porru M, et al
    Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    PLoS One. 2018;13:e0203426.
    PubMed     Abstract available


  386. TAMAYO LI, Vidaurre T, Navarro Vasquez J, Casavilca S, et al
    Breast cancer subtype and survival among Indigenous American women in Peru.
    PLoS One. 2018;13:e0201287.
    PubMed     Abstract available


  387. XU S, Thompson W, Kerr J, Godbole S, et al
    Modeling interrelationships between health behaviors in overweight breast cancer survivors: Applying Bayesian networks.
    PLoS One. 2018;13:e0202923.
    PubMed     Abstract available


  388. MON AM, MacKinnon AC Jr, Traktman P
    Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2018;13:e0203397.
    PubMed     Abstract available


  389. GONG IY, Fox NS, Huang V, Boutros PC, et al
    Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    PLoS One. 2018;13:e0204123.
    PubMed     Abstract available


  390. TAN MM, Ho WK, Yoon SY, Mariapun S, et al
    A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
    PLoS One. 2018;13:e0203469.
    PubMed     Abstract available


  391. LI G, Guo X, Chen M, Tang L, et al
    Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    PLoS One. 2018;13:e0203495.
    PubMed     Abstract available


  392. YOO J, Kim BS, Chung J, Yoon HJ, et al
    Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
    PLoS One. 2018;13:e0203649.
    PubMed     Abstract available


  393. LI J, Chen X, Qi M, Li Y, et al
    Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204364.
    PubMed     Abstract available


  394. CHANCHAN G, Xiangyu S, Fangfang S, Yan C, et al
    The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.
    PLoS One. 2018;13:e0204202.
    PubMed     Abstract available


  395. CALAHORRA J, Martinez-Lara E, De Dios C, Siles E, et al
    Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0203892.
    PubMed     Abstract available


  396. DING LY, Chu M, Jiao YS, Hao Q, et al
    TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
    PLoS One. 2018;13:e0203833.
    PubMed     Abstract available


  397. LIN PH, Yang HJ, Hsieh WC, Lin C, et al
    Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.
    PLoS One. 2018;13:e0201241.
    PubMed     Abstract available


  398. FOUAD TM, Ueno NT, Yu RK, Ensor JE, et al
    Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
    PLoS One. 2018;13:e0204372.
    PubMed     Abstract available


  399. KAZEMI NOUREINI S, Fatemi L, Wink M
    Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
    PLoS One. 2018;13:e0204901.
    PubMed     Abstract available



  400. Retraction: Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1alpha Accumulation via Increased Production of Reactive Oxygen Species.
    PLoS One. 2018;13:e0205288.
    PubMed    


  401. GOKMEN-POLAR Y, True JD, Vieth E, Gu Y, et al
    Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
    PLoS One. 2018;13:e0204658.
    PubMed     Abstract available


  402. COLLIGNON O, Han J, An H, Oh S, et al
    Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancer.
    PLoS One. 2018;13:e0204897.
    PubMed     Abstract available


  403. ANSARIPOUR A, Zendehdel K, Tadayon N, Sadeghi F, et al
    Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
    PLoS One. 2018;13:e0205079.
    PubMed     Abstract available


  404. ZUGNI F, Ruju F, Pricolo P, Alessi S, et al
    The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
    PLoS One. 2018;13:e0205251.
    PubMed     Abstract available


  405. HARANO K, Wang Y, Lim B, Seitz RS, et al
    Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
    PLoS One. 2018;13:e0204513.
    PubMed     Abstract available


  406. VAN TREUREN T, Vishwanatha JK
    CRISPR deletion of MIEN1 in breast cancer cells.
    PLoS One. 2018;13:e0204976.
    PubMed     Abstract available


  407. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0206026.
    PubMed     Abstract available


  408. ALOTAIBI RM, Rezk HR, Juliana CI, Guure C, et al
    Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors.
    PLoS One. 2018;13:e0206148.
    PubMed     Abstract available


  409. DUMANE VA, Bakst R, Green S
    Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
    PLoS One. 2018;13:e0205770.
    PubMed     Abstract available


  410. COVARRUBIAS G, Cha A, Rahmy A, Lorkowski M, et al
    Imaging breast cancer using a dual-ligand nanochain particle.
    PLoS One. 2018;13:e0204296.
    PubMed     Abstract available


  411. SEMLALI A, Almutairi M, Rouabhia M, Reddy Parine N, et al
    Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.
    PLoS One. 2018;13:e0203376.
    PubMed     Abstract available


  412. ROCHA-BRISCHILIARI SC, Andrade L, Nihei OK, Brischiliari A, et al
    Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil.
    PLoS One. 2018;13:e0205253.
    PubMed     Abstract available


  413. VENUGOPAL V, Krishnan S, Palanimuthu VR, Sankarankutty S, et al
    Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    PLoS One. 2018;13:e0206109.
    PubMed     Abstract available


  414. BEZERRA IC, da Silva RM, Oliveira CP, Brasil CCP, et al
    Mastectomized women's perception of breast cancer early detection.
    PLoS One. 2018;13:e0206405.
    PubMed     Abstract available


  415. SALAGAME U, Banks E, O'Connell DL, Egger S, et al
    Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    PLoS One. 2018;13:e0205034.
    PubMed     Abstract available


  416. CUELLO-LOPEZ J, Fidalgo-Zapata A, Lopez-Agudelo L, Vasquez-Trespalacios E, et al
    Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2018;13:e0207224.
    PubMed     Abstract available



  417. Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0206720.
    PubMed     Abstract available


  418. CAMPOS-RODRIGUEZ F, Cruz-Medina A, Selma MJ, Rodriguez-de-la-Borbolla-Artacho M, et al
    Association between sleep-disordered breathing and breast cancer aggressiveness.
    PLoS One. 2018;13:e0207591.
    PubMed     Abstract available


  419. KWON MJ, Lee SB, Han J, Lee JE, et al
    BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
    PLoS One. 2018;13:e0207155.
    PubMed     Abstract available


  420. ALSHAREEDA AT, Rakha E, Alghwainem A, Alrfaei B, et al
    The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    PLoS One. 2018;13:e0207593.
    PubMed     Abstract available


  421. MBOGE MY, Chen Z, Wolff A, Mathias JV, et al
    Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2018;13:e0207417.
    PubMed     Abstract available


  422. GROSSE FRIE K, Kamate B, Traore CB, Ly M, et al
    Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali.
    PLoS One. 2018;13:e0207928.
    PubMed     Abstract available


  423. GOKAL K, Munir F, Ahmed S, Kancherla K, et al
    Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    PLoS One. 2018;13:e0206874.
    PubMed     Abstract available


  424. SUN L, Legood R, Dos-Santos-Silva I, Gaiha SM, et al
    Global treatment costs of breast cancer by stage: A systematic review.
    PLoS One. 2018;13:e0207993.
    PubMed     Abstract available


  425. DAVIS M, Tripathi S, Hughley R, He Q, et al
    AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
    PLoS One. 2018;13:e0196909.
    PubMed     Abstract available


  426. BALOGH KN, Templeton DJ, Cross JV
    Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    PLoS One. 2018;13:e0197702.
    PubMed     Abstract available


  427. KOUTRAS A, Lazaridis G, Koliou GA, Kouvatseas G, et al
    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
    PLoS One. 2018;13:e0207707.
    PubMed     Abstract available


  428. BOU-DARGHAM MJ, Liu Y, Sang QA, Zhang J, et al
    Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
    PLoS One. 2018;13:e0207799.
    PubMed     Abstract available


  429. MADDEN JM, Duffy MJ, Zgaga L, Bennett K, et al
    Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study.
    PLoS One. 2018;13:e0209033.
    PubMed     Abstract available


  430. CINGIR KOKER S, Jahja E, Shehwana H, Keskus AG, et al
    Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.
    PLoS One. 2018;13:e0208982.
    PubMed     Abstract available


  431. BANG JI, Yoon HJ, Kim BS
    Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.
    PLoS One. 2018;13:e0208861.
    PubMed     Abstract available


  432. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    PubMed     Abstract available


  433. WALKER AK, Chang A, Ziegler AI, Dhillon HM, et al
    Low dose aspirin blocks breast cancer-induced cognitive impairment in mice.
    PLoS One. 2018;13:e0208593.
    PubMed     Abstract available


  434. QIU L, Levine K, Gajiwala KS, Cronin CN, et al
    Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
    PLoS One. 2018;13:e0198374.
    PubMed     Abstract available


  435. PRAGER M, Kiechle M, Stollenwerk B, Hinzen C, et al
    Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.
    PLoS One. 2018;13:e0198137.
    PubMed     Abstract available


  436. MYUNG Y, Son Y, Nam TH, Kang E, et al
    Objective assessment of flap volume changes and aesthetic results after adjuvant radiation therapy in patients undergoing immediate autologous breast reconstruction.
    PLoS One. 2018;13:e0197615.
    PubMed     Abstract available


  437. SRIMUNINNIMIT V, Pornpraserthsuk P, Chaiwerawattana A, Kongdan Y, et al
    Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer.
    PLoS One. 2018;13:e0209040.
    PubMed     Abstract available


  438. CHEN FP, Chien MH, Chen HY, Ng YT, et al
    Effects of phthalates on normal human breast cells co-cultured with different fibroblasts.
    PLoS One. 2018;13:e0199596.
    PubMed     Abstract available


  439. HAHN EC, Bittar CM, Vianna FSL, Netto CBO, et al
    TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    PLoS One. 2018;13:e0209934.
    PubMed     Abstract available


  440. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Abstract available


  441. TEA MM, Tan YY, Staudigl C, Eibl B, et al
    Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool.
    PLoS One. 2018;13:e0200559.
    PubMed     Abstract available


  442. ONISHI H, Udagawa C, Kubo M, Nakamura S, et al
    A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.
    PLoS One. 2018;13:e0201606.
    PubMed     Abstract available


  443. HONG JH, Ko YH, Kang K
    RNA variant identification discrepancy among splice-aware alignment algorithms.
    PLoS One. 2018;13:e0201822.
    PubMed     Abstract available


  444. BISWENGER V, Baumann N, Jurschick J, Hackl M, et al
    Characterization of EGF-guided MDA-MB-231 cell chemotaxis in vitro using a physiological and highly sensitive assay system.
    PLoS One. 2018;13:e0203040.
    PubMed     Abstract available


  445. NAGORSKI J, Allen GI
    Genomic region detection via Spatial Convex Clustering.
    PLoS One. 2018;13:e0203007.
    PubMed     Abstract available


  446. JOSE V, Fumagalli D, Rothe F, Majjaj S, et al
    Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays.
    PLoS One. 2018;13:e0203346.
    PubMed     Abstract available


  447. XIE L, Sun Z, Hong Z, Brown NJ, et al
    Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.
    PLoS One. 2018;13:e0204418.
    PubMed     Abstract available


  448. JUNG H, Kim B, Lee I, Yoo M, et al
    Detection of masses in mammograms using a one-stage object detector based on a deep convolutional neural network.
    PLoS One. 2018;13:e0203355.
    PubMed     Abstract available


  449. SERGANOVA I, Cohen IJ, Vemuri K, Shindo M, et al
    LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
    PLoS One. 2018;13:e0203965.
    PubMed     Abstract available


  450. OU J, Si Y, Goh K, Yasui N, et al
    Bioprocess development of antibody-drug conjugate production for cancer treatment.
    PLoS One. 2018;13:e0206246.
    PubMed     Abstract available


  451. ALKARAKOOLY Z, Al-Anbaky QA, Kannan K, Ali N, et al
    Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells.
    PLoS One. 2018;13:e0206182.
    PubMed     Abstract available


  452. JINESH GG, Flores ER, Brohl AS
    Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.
    PLoS One. 2018;13:e0206008.
    PubMed     Abstract available


  453. JOO MW, Kang YK, Ogura K, Iwata S, et al
    Post-radiation sarcoma: A study by the Eastern Asian Musculoskeletal Oncology Group.
    PLoS One. 2018;13:e0204927.
    PubMed     Abstract available


  454. DHAGE S, Ernlund A, Ruggles K, Axelrod D, et al
    A genomic ruler to assess oncogenic transition between breast tumor and stroma.
    PLoS One. 2018;13:e0205602.
    PubMed     Abstract available


  455. KUMAR V, Denis M, Gregory A, Bayat M, et al
    Viscoelastic parameters as discriminators of breast masses: Initial human study results.
    PLoS One. 2018;13:e0205717.
    PubMed     Abstract available


  456. COTTU PH, Bonneterre J, Varga A, Campone M, et al
    Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
    PLoS One. 2018;13:e0204973.
    PubMed     Abstract available


  457. STARLARD-DAVENPORT A, Allman R, Dite GS, Hopper JL, et al
    Validation of a genetic risk score for Arkansas women of color.
    PLoS One. 2018;13:e0204834.
    PubMed     Abstract available


  458. WANG K, Duan X, Gao F, Wang W, et al
    Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
    PLoS One. 2018;13:e0203824.
    PubMed     Abstract available


  459. BURTON LJ, Hawsawi O, Loyd Q, Henderson V, et al
    Association of Epithelial Mesenchymal Transition with prostate and breast health disparities.
    PLoS One. 2018;13:e0203855.
    PubMed     Abstract available


  460. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
    Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
    PLoS One. 2018;13:e0206467.
    PubMed     Abstract available


  461. CHIANG YS, Huang YF, Midha MK, Chen TH, et al
    Single cell transcriptome analysis of MCF-7 reveals consistently and inconsistently expressed gene groups each associated with distinct cellular localization and functions.
    PLoS One. 2018;13:e0199471.
    PubMed     Abstract available


  462. LIN ZP, Zhu YL, Lo YC, Moscarelli J, et al
    Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.
    PLoS One. 2018;13:e0207399.
    PubMed     Abstract available


  463. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Abstract available


    January 2017
  464. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    PubMed     Abstract available


  465. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    PubMed     Abstract available


  466. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    PubMed     Abstract available


  467. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    PubMed     Abstract available


  468. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    PubMed     Abstract available


  469. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    PubMed     Abstract available


  470. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    PubMed     Abstract available


  471. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    PubMed     Abstract available


  472. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    PubMed     Abstract available


  473. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    PubMed     Abstract available


  474. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    PubMed     Abstract available


  475. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    PubMed     Abstract available


  476. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    PubMed     Abstract available


  477. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    PubMed     Abstract available


  478. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    PubMed     Abstract available


  479. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    PubMed     Abstract available


  480. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    PubMed     Abstract available


  481. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    PubMed     Abstract available


  482. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Abstract available


  483. MARQUEZ-RODAS I, Pollan M, Escudero MJ, Ruiz A, et al
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Alamo III" retrospective study.
    PLoS One. 2017;12:e0184181.
    PubMed     Abstract available


  484. CILEK EE, Ozturk H, Gur Dedeoglu B
    Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    PLoS One. 2017;12:e0185558.
    PubMed     Abstract available


  485. AUKES K, Forsman C, Brady NJ, Astleford K, et al
    Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
    PLoS One. 2017;12:e0185736.
    PubMed     Abstract available


  486. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    PubMed     Abstract available


  487. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    PubMed     Abstract available


  488. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    PubMed     Abstract available


  489. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    PubMed     Abstract available


  490. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    PubMed     Abstract available


  491. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Abstract available


  492. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    PubMed     Abstract available


  493. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Abstract available


  494. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Abstract available


  495. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    PubMed     Abstract available


  496. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    PubMed     Abstract available


  497. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    PubMed     Abstract available


  498. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    PubMed     Abstract available


  499. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Abstract available


  500. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    PubMed     Abstract available


  501. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    PubMed     Abstract available


  502. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    PubMed     Abstract available


  503. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    PubMed     Abstract available


  504. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    PubMed     Abstract available


  505. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    PubMed     Abstract available


  506. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    PubMed     Abstract available


  507. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    PubMed     Abstract available


  508. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    PubMed     Abstract available


  509. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    PubMed     Abstract available


  510. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    PubMed     Abstract available


  511. HIRONAKA-MITSUHASHI A, Matsuzaki J, Takahashi RU, Yoshida M, et al
    A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
    PLoS One. 2017;12:e0187638.
    PubMed     Abstract available


  512. SYED S, Schober J, Blanco A, Zustiak SP, et al
    Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates.
    PLoS One. 2017;12:e0187853.
    PubMed     Abstract available


  513. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    PubMed     Abstract available


  514. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    PubMed     Abstract available


  515. THOMPSON KJ, Ingle JN, Tang X, Chia N, et al
    A comprehensive analysis of breast cancer microbiota and host gene expression.
    PLoS One. 2017;12:e0188873.
    PubMed     Abstract available


  516. MARINHO EDC, Custodio IDD, Ferreira IB, Crispim CA, et al
    Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study.
    PLoS One. 2017;12:e0187573.
    PubMed     Abstract available


  517. AZIZI M, Ghourchian H, Yazdian F, Dashtestani F, et al
    Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231.
    PLoS One. 2017;12:e0188639.
    PubMed     Abstract available


  518. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martin-Perez J, et al
    miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
    PLoS One. 2017;12:e0188637.
    PubMed     Abstract available


  519. ARENAS M, Garcia-Heredia A, Cabre N, Luciano-Mateo F, et al
    Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
    PLoS One. 2017;12:e0188633.
    PubMed     Abstract available


  520. AHN SG, Bae SJ, Yoon C, Cha YJ, et al
    Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
    PLoS One. 2017;12:e0187679.
    PubMed     Abstract available


  521. ZEUNE L, van Dalum G, Decraene C, Proudhon C, et al
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
    PLoS One. 2017;12:e0186562.
    PubMed     Abstract available


  522. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    PubMed     Abstract available


  523. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    PubMed     Abstract available


  524. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    PubMed     Abstract available


  525. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    PubMed     Abstract available


  526. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    PubMed     Abstract available


  527. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    PubMed     Abstract available


  528. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    PubMed     Abstract available


  529. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    PubMed     Abstract available


  530. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    PubMed     Abstract available


  531. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    PubMed     Abstract available


  532. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    PubMed     Abstract available


  533. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    PubMed     Abstract available


  534. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    PubMed     Abstract available


  535. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    PubMed     Abstract available


  536. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    PubMed     Abstract available


  537. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    PubMed     Abstract available


  538. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    PubMed     Abstract available


  539. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    PubMed     Abstract available


  540. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    PubMed     Abstract available


  541. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    PubMed     Abstract available


  542. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    PubMed     Abstract available


  543. JIN D, Lee H
    FGMD: A novel approach for functional gene module detection in cancer.
    PLoS One. 2017;12:e0188900.
    PubMed     Abstract available


  544. PAUL B, Royston KJ, Li Y, Stoll ML, et al
    Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
    PLoS One. 2017;12:e0189756.
    PubMed     Abstract available


  545. HANLEY JA, Hannigan A, O'Brien KM
    Mortality reductions due to mammography screening: Contemporary population-based data.
    PLoS One. 2017;12:e0188947.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: